Envista Holdings (NVST) Change in Account Payables (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Change in Account Payables of -$21.4 million in Q2 2026, down 164.07% quarter-over-quarter from $33.4 million in Q4 2025, and down 41.72% on a YoY basis from -$36.7 million in Q2 2025.
Envista Holdings (NVST) Change in Account Payables (2018 - 2026) Analysis & Trends
Envista Holdings' Change in Account Payables history runs 9 years deep, the most recent figure standing at -$21.4 million for Q2 2026.
- In Q2 2026, Change in Account Payables fell 41.72% year-over-year to -$21.4 million; the TTM figure through Apr 2026 stood at $1.2 million (up 108.82% YoY), while the FY2025 annual figure was $7.5 million, up 725.0% from the prior year.
- Change in Account Payables was -$21.4 million for Q2 2026 at Envista Holdings, down from $33.4 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $33.4 million in Q4 2025 to a low of -$38.1 million in Q1 2023.
- Historically, Change in Account Payables has averaged -$994117.6 across 5 years, with a median of -$2.5 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables slumped 1424.0% in 2023, then surged 430.16% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $33.2 million in 2022, then sank by 79.22% to $6.9 million in 2023, then retreated by 8.7% to $6.3 million in 2024, then soared by 430.16% to $33.4 million in 2025, then tumbled by 164.07% to -$21.4 million in 2026.
- The last three Change in Account Payables figures came in at -$21.4 million (Q2 2026), $33.4 million (Q4 2025), and -$15.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 73.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 6.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 23.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 4.93 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 102.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | -21.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -21.40 Mn |
| Apr 3, 2026 | -21.40 Mn |
| Dec 31, 2025 | 33.40 Mn |
| Dec 31, 2025 | 33.40 Mn |
| Sep 26, 2025 | -15.90 Mn |
| Sep 26, 2025 | -15.90 Mn |
| Jun 27, 2025 | 5.10 Mn |
| Jun 27, 2025 | 5.10 Mn |
| Mar 28, 2025 | -15.10 Mn |
| Mar 28, 2025 | -15.10 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Sep 27, 2024 | -2.50 Mn |
| Sep 27, 2024 | -2.50 Mn |
| Jun 28, 2024 | -2.30 Mn |
| Jun 28, 2024 | -2.30 Mn |
| Mar 29, 2024 | -2.70 Mn |
| Mar 29, 2024 | -2.70 Mn |
| Dec 31, 2023 | 6.90 Mn |
| Dec 31, 2023 | 6.90 Mn |